MDMA-Assisted Psychotherapy: Current State of Affairs and the Road Ahead
This presentation reviewed the state of research on MDMA-Assisted Psychotherapy, with a focus on results from the Multidisciplinary Association on Psychedelic Studies (MAPS) Phase 2 clinical trials of MDMA-Assisted Psychotherapy for PTSD. In addition, basic principles of the MDMA-Assisted Psychotherapy method (according to the MAPS protocol) were discussed, including specific elements of preparatory sessions, MDMA-assisted sessions, and integration sessions. Finally, considerations for therapists wishing to be trained in this method (as well as in complementary psychotherapeutic techniques) were highlighted.
Alissa Bazinet, Ph.D.
Alissa Bazinet, Ph.D. is a licensed clinical psychologist currently in private practice at Somatic Center Portland, LLC (a collective of independent practitioners working from a holistic perspective to treat mental and physical health imbalances), where she specializes in mindfulness-based and emotion-focused approaches to working with adults with histories of trauma, addictions, depression, anxiety, and chronic pain/illness. She received her Ph.D. in 2013 from the University of California, San Diego/San Diego State University’s joint doctoral program in clinical psychology and neuropsychology, and has over ten years of experience in the research and treatment of substance use disorders and PTSD, particularly in Veteran populations. She is currently in training through the MAPS MDMA Therapist Training Program and an ongoing volunteer for the Zendo Project, an organization that provides psychedelic harm reduction and peer support services at music festivals and events throughout the world.